BioElectronics to Sense and Treat (BEST)
ID: DARPA-PS-25-12Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)DEF ADVANCED RESEARCH PROJECTS AGCYARLINGTON, VA, 222032114, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH (AC12)
Timeline
    Description

    The Department of Defense, through the Defense Advanced Research Projects Agency (DARPA), is seeking proposals for the BioElectronics to Sense and Treat (BEST) program, which aims to develop an automated bioelectronic smart bandage for managing wound infections in military settings. The program's objectives include creating a device that can continuously monitor wounds, predict infections, and autonomously administer treatments, thereby enhancing military medical care and potentially benefiting civilian healthcare. DARPA has allocated approximately $22.8 million for multiple awards, with full proposals due by May 8, 2025, and key milestones including an Industry Day on February 19, 2025, and abstract submissions by March 25, 2025. Interested parties can contact Dr. Leonard Tender at BEST@darpa.mil for further information.

    Point(s) of Contact
    Dr. Leonard Tender
    BEST@darpa.mil
    Files
    Title
    Posted
    The document outlines a proposal related to the DARPA initiative titled "BioElectronics to Sense and Treat" (BEST). It focuses on the development of a novel technical approach that integrates bioelectronics for sensing and therapeutic applications. The structure includes a graphical representation of the approach, a summary of its uniqueness, and an assessment of key risks along with potential mitigation strategies. The proposal details estimated costs by phase, including labor and materials, and outlines the intended schedule for the project's execution. Furthermore, it emphasizes the qualifications and experience of team members and the organizational capabilities relevant to the project. The proposal underscores the importance of collaboration and strategic planning in addressing the research goals set forth by DARPA, aligning with broader federal grant and RFP initiatives aimed at advancing technology in healthcare. Overall, the document aims to secure funding and support for innovative bioelectronic solutions in medical treatment scenarios.
    The DARPA-PS-25-12 BioElectronics to Sense and Treat (BEST) program solicitation outlines the submission requirements for proposals aimed at addressing technical problems related to bioelectronics. It mandates the use of a specific abstract template, limiting submissions to a maximum of five pages, excluding supporting materials. Proposals must detail an executive summary, the proposed technical approach, anticipated technical challenges, team capabilities, estimated costs, and references. Each section focuses on critical components such as the justification of the proposed work's novelty, identification of risks, and demonstration of the team's qualifications. Estimated costs should cover labor and materials across project phases, with travel expenses to key meetings pre-calculated. The ultimate goal of the BEST program is to foster innovative solutions in bioelectronics that can effectively sense and treat medical conditions while evaluating the potential risks and challenges involved in development. Adherence to formatting and scheduling guidelines is essential for submission consideration, underscoring the program's rigorous selection process.
    Attachment C of DARPA-PS-25-12 provides mandatory guidelines for the Technical and Management Proposal submissions for the BEST program. Proposals must follow a prescribed format, not exceed 30 pages, and include specific attachments. Key elements include a cover sheet, a proposal summary, goals and impact, a technical plan, organizational capabilities, a task description document, a detailed schedule, a management plan, and personnel qualifications. Each proposal requires clear articulation of the project's objectives, technical challenges, innovation, and impact, with an emphasis on concise descriptions and measurable milestones. Additional requirements address conflicts of interest, intellectual property considerations, and proof of eligibility for participation from government entities or federally funded research and development centers. Proposals must be submitted by the specified deadline in compliance with DARPA's submission guidelines. This document serves as a comprehensive template aimed at standardizing proposal submissions while ensuring critical evaluations of innovative approaches in defense-related projects.
    The document serves as a mandatory template for cost proposal submissions related to DARPA's PS-25-12 program, focusing on both base and option phases. It outlines structured guidelines for proposers to follow, ensuring all cost-related information is presented clearly and comprehensively within specified formats. Key components include detailed breakdowns of direct labor, indirect costs, materials, equipment purchases, and travel, among others. Proposers must utilize a standard spreadsheet for cost calculations and ensure traceability of costs between prime contractors and subawardees. Additionally, the document stresses the responsibility of the prime proposer in submitting complete non-proprietary cost proposals from all subcontractors, with instructions on handling proprietary submissions. Specific requirements are stated for contractors seeking procurement contracts versus those applying for other transaction agreements for prototypes, including certifications, consultations, and cost-sharing details. The structured approach aims to facilitate expeditious government analysis and negotiation of proposals, emphasizing accurate and substantiated pricing and milestone reporting. Overall, the document reflects a thorough framework for ensuring compliance and fostering clarity in government acquisitions and research funding.
    The DARPA Standard Cost Proposal Spreadsheet is a tool for proposers to prepare cost proposals for government projects, including opportunities under RFPs and grants. It requires detailed documentation of costs, including direct labor, overhead, subcontractor, and consultant expenses, which must be fully supported and rationalized for review by government personnel. The spreadsheet encompasses various worksheets detailing labor rates, indirect costs, and materials needed for complete proposals, ensuring compliance with regulatory standards outlined in the FAR. Proposers must enter data into specified fields for clear financial analysis and be mindful of maintaining the integrity of the spreadsheet's structure. The primary aim is to streamline the proposal process, facilitating rapid government evaluation and contract negotiations while emphasizing the importance of accuracy and completeness in cost reporting. Feedback on the spreadsheet's functionality is encouraged to enhance its usability for future proposals. Overall, the document serves as a critical guideline for structuring comprehensive cost proposals for federal support.
    The document outlines a Risk Register following the Department of Defense (DoD) framework for categorizing risks associated with federal government projects, particularly in response to RFPs and grants. It includes structured elements such as task/milestone, risk statement, associated problems, likelihood of occurrence, and consequences impacting cost, schedule, and performance. Risks are evaluated using a 1-5 scale for both likelihood and consequence, resulting in categorized risk levels such as high, moderate, and low. The document serves as a template for project managers to identify and mitigate potential risks effectively, ensuring that they adhere to defined standards and frameworks. By systematically documenting risks, the register aims to enhance project management practices and increase the success rate of federal projects.
    The document outlines the framework for an Other Transaction Agreement (OTA) between DARPA and a research performer. It provides a structure for collaboration in the development of a prototype under 10 U.S.C. § 4022, emphasizing that the final terms may differ from the provided model. Key areas include the scope of work, funding obligations, project management, patent rights, data rights, and security protocols for handling covered defense information. Proposers are allowed to suggest edits to the essential terms but such changes will not affect the evaluation of proposals. The agreement requires detailed milestone reporting and active government engagement through regular reviews. Furthermore, it stipulates conditions regarding the sharing of technology with foreign partners and mandates stringent cybersecurity measures. The overarching purpose is to foster innovation while safeguarding national interests. This comprehensive agreement serves as a foundational tool for successful collaboration between the government and the private sector in advancing critical technologies.
    The document outlines the requirements for a Task Description Document that must accompany federal government RFPs, federal grants, and state/local RFPs. Its primary objective is to structure and clarify the proposer's research plan through defined tasks and subtasks, which should lead to technical milestones specified in a separate attachment. The document emphasizes writing in the third person and providing a detailed description of each task's objectives, the approach to be taken, and the estimated completion dates along with associated milestones. Key components include the organization and location of the project work as well as measurable deliverables to track task progress. Proposers are instructed to refrain from including proprietary information and to ensure clarity in presenting their methodologies and outcomes. This systematic breakdown is essential for evaluating proposals and ensuring compliance with specified requirements.
    The document outlines requirements for completing a "Schedule of Milestones and Payments" as part of a federal request for proposals (RFP) under the BEST program. It emphasizes the importance of aligning tasks and deliverables with the specifications detailed in accompanying documents. Proposers are to populate a provided spreadsheet with milestones, deliverables, and payment details, while adhering to specific formatting guidelines: black text for required items, blue for edits, and red for new additions. Key milestones include kick-off meetings, monthly reports, technical interchange meetings, and various phases of design reviews and validations for the FA1, FA2, and FA3 devices. Additionally, regulatory, commercialization, and technical deliverables are specified with due dates following contract award. It highlights the importance of documenting all progress and signifies that payments for each milestone should align with costs outlined in the cost proposal. The overarching goal is to ensure accountability and thorough progress assessment throughout the program lifecycle, ensuring that participants meet stringent technical and regulatory objectives while advancing project deliverables effectively.
    Amendment 1 to the DARPA-PS-25-12 BioElectronics to Sense and Treat (BEST) Program Solicitation is aimed at extending the deadlines for proposals related to the program. Key dates for the solicitation include the posting date on February 25, 2025, and the Industry Day scheduled for February 19, 2025. Abstract submissions are due by March 25, 2025, with related questions due by March 18, 2025. The full proposals must be submitted by May 8, 2025, with inquiries regarding proposals due by April 29, 2025. This extension is crucial for potential applicants to prepare their submissions adequately and ensure comprehensive responses to the program's objectives. The document serves as a formal communication to stakeholders involved in federal grant opportunities associated with bioelectronics technology.
    The Defense Advanced Research Projects Agency (DARPA) has announced a funding opportunity for the BioElectronics to Sense and Treat (BEST) program, aimed at developing an automated bioelectronic smart bandage for wound infection management in military settings. The bandage will monitor wounds in real-time, predict infections, and administer targeted treatments autonomously. DARPA allocates approximately $22.8 million for multiple awards, with a full proposal deadline of May 6, 2025. The program is structured in two phases, focusing on developing sensing and treatment technologies in Phase I, and integrating these into a closed-loop control system in Phase II. Key performance objectives include achieving over 80% accuracy in predicting healing outcomes and diagnosing infections. Proposals must address all three focus areas: Sense, Treat, and Closed-Loop Control, and demonstrate an effective strategy for transitioning the technology to clinical use. The solicitation underscores the importance of developing innovative solutions to combat wound infections, enhancing military medical care while potentially benefiting civilian healthcare as well.
    Lifecycle
    Title
    Type
    Solicitation
    Similar Opportunities
    Smart Red Blood Cells (Smart-RBC)
    Buyer not available
    The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals for the Smart Red Blood Cells (Smart-RBC) program, which aims to engineer red blood cells with novel biological features to safely and temporarily alter human physiology. The program seeks to develop "smart red blood cells" (SRBCs) that can sense extracellular biomarkers, decide on actions, and act by producing effector molecules to enhance human performance and maximize survival, particularly in hemostasis. With approximately $35.1 million in total funding, the program spans 36 months and is divided into two phases, focusing on the development of biological circuits and culminating in a capability demonstration. Interested parties should contact Dr. Christopher Bettinger at Smart-RBC@darpa.mil for further details, and proposals must adhere to specific guidelines, including the submission of abstracts and oral presentations scheduled for January 2026.
    Biological Technologies
    Buyer not available
    The Defense Advanced Research Projects Agency (DARPA) is soliciting proposals for its Biological Technologies Office (BTO) under Broad Agency Announcement HR001126S0003, aimed at leveraging biological properties and processes to enhance the protection of U.S. warfighters. The BAA invites innovative research proposals that focus on various areas, including biological and chemical technologies for national security, AI/ML applications, combat casualty care, and environmental solutions, with a clear exclusion of evolutionary improvements to existing practices. Proposals will be evaluated based on scientific merit, relevance to DARPA's mission, and cost realism, with multiple award types anticipated, including contracts and cooperative agreements, and an accelerated award option available for proposals under $2 million. Interested parties should submit abstracts and proposals on a rolling basis until September 30, 2026, and can contact the BAA Coordinator at BTOBAA2026@darpa.mil for further information.
    ADVANCED TECHNOLOGIES FOR COMBAT CASUALTY CARE (CCC) RFI
    Buyer not available
    The Defense Advanced Research Projects Agency (DARPA) is issuing a Request for Information (RFI) to gather insights on advanced medical technologies for Combat Casualty Care (CCC) in challenging environments. This RFI aims to solicit input from industry, academia, government laboratories, and non-traditional performers regarding innovative medical sensing, computational, modeling, actuation, therapeutic, and robotics technologies that can enhance care from point-of-injury through prolonged and surgical care. The focus is on capabilities that can provide rapid diagnosis, predictive modeling, automated interventions, and resilience in resource-constrained settings. Interested parties should note that the deadline for submissions has been revised to December 17, 2025, at 4:00 PM ET, and can direct inquiries to Dr. Roozbeh Jafari at CCCxBTO@darpa.mil.
    Strategic Technology Office-wide Broad Agency Announcement
    Buyer not available
    The Defense Advanced Research Projects Agency (DARPA) is seeking innovative research proposals through its Strategic Technology Office-wide Broad Agency Announcement (BAA) HR001125S0001, which is open until December 19, 2025. The BAA aims to fund revolutionary advances in science, devices, or systems that enhance U.S. military and national security capabilities, specifically excluding evolutionary improvements to existing technologies. Proposals should address a wide range of topics, including artificial intelligence, autonomy, advanced computing, and communications, with the goal of developing disruptive technologies for future battlespaces. Interested parties can contact the BAA Coordinator at HR001125S0001@darpa.mil for further information and are encouraged to submit abstracts prior to full proposals to ensure alignment with DARPA's mission and avoid duplication of existing efforts.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
    Buyer not available
    The Department of Defense, through the United States Special Operations Command (USSOCOM), is soliciting proposals for the Broad Agency Announcement (BAA) focused on Extramural Biomedical and Human Performance Research and Development, which will be open from August 1, 2023, to July 31, 2028. This initiative aims to enhance military medical capabilities by funding innovative research addressing critical areas such as trauma care, brain health, casualty management, and human performance optimization, with individual project budgets ranging from $700,000 to $5 million. The research funded under this BAA is intended to benefit both military and civilian medical practices, emphasizing the importance of applicable solutions for unique operational environments. Interested organizations, including non-profits and educational institutions, must submit a pre-proposal via the electronic Biomedical Research Application Portal (eBRAP) before being invited to submit a full proposal through Grants.gov, with a total annual funding budget of $10 million available for selected projects. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or Jessee Chege at jessee.t.chege.civ@health.mil.
    DLA Emergent IV Research and Development Program
    Buyer not available
    The Defense Logistics Agency (DLA) is seeking proposals for the Emergent IV Research and Development Program, a Broad Agency Announcement (BAA) aimed at advancing innovative research in various areas of interest, including medical logistics, advanced manufacturing, and artificial intelligence applications. The program invites interested parties to submit "White Papers" that outline specific projects related to the identified areas, with the potential for selected submissions to lead to requests for full technical and cost proposals. This initiative is crucial for enhancing the DLA's logistics capabilities and operational efficiency, with a total funding ceiling of $125 million over a five-year period. Interested vendors can reach out to the DLA's R&D Mailbox at RandD.DCSO@dla.mil for further inquiries, and must adhere to the established submission timelines, with key deadlines for White Papers set for April 19 and April 26, 2024.
    TTO Office Wide (OW) BAA 2025
    Buyer not available
    The Department of Defense, through the Defense Advanced Research Projects Agency (DARPA), is soliciting innovative proposals under the Broad Agency Announcement (BAA) titled "TTO Office Wide (OW) BAA 2025." This initiative aims to enhance national security by fostering technological advancements in areas such as system design, manufacturing, and disruptive innovation, with a focus on improving military capabilities and operational effectiveness. Proposals should align with DARPA's mission to create revolutionary platforms and systems, and must adhere to specific submission guidelines, including a maximum of 25 pages for technical proposals and a two-page limit for executive summaries. Interested parties must submit their proposals by June 22, 2026, and can direct inquiries to the BAA Coordinator at HR001125S0011@darpa.mil.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
    Buyer not available
    Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.
    Research and Development Innovations Broad Agency Announcement
    Buyer not available
    The Defense Threat Reduction Agency (DTRA) is soliciting innovative research and development proposals through its Broad Agency Announcement (BAA) HDTRA1-22-S-0003, aimed at countering weapons of mass destruction (WMD) and emerging threats. The BAA invites proposals for technologies at Technology Readiness Levels (TRL) 1-7, focusing on five key thrust areas: understanding WMD threats, enabling deterrence, controlling and defeating threats, protecting forces, and cross-cutting capabilities. This multi-year solicitation, active from February 2022 to February 2027, anticipates contract awards ranging from $500,000 to $5,000,000 over 1-3 years, with a two-phased proposal process. Interested parties should direct inquiries to the BAA Program Manager at dtra.belvoir.rd.mbx.rd-baa-inbox@mail.mil, and adhere to submission deadlines, including a final proposal submission date of September 19, 2025, for the latest addendum.
    BROAD AGENCY ANNOUNCEMENT - BIOMEDICAL RESEARCH AND DIVING EQUIPMENT DEVELOPMENT
    Buyer not available
    The Department of Defense, specifically the Naval Sea Systems Command (NAVSEA), is soliciting proposals through a Broad Agency Announcement (BAA) for biomedical research and diving equipment development aimed at enhancing diver health, safety, and performance, as well as submarine escape and rescue capabilities. The primary objectives include improving diving equipment and biomedical aspects related to diver operations, with a focus on areas such as breathing gas supply, human performance, environmental protection, decompression, and submarine rescue strategies. This initiative is critical for advancing the safety and effectiveness of Navy personnel during underwater operations, with contracts typically averaging around $300,000 annually. Interested parties must submit pre-proposals by November 30, 2024, for FY26 funding, with full proposals due by February 28, 2025. For further inquiries, contact Lisa Grayum at lisa.m.grayum.civ@us.navy.mil or Daniel Kough at daniel.w.kough2.civ@us.navy.mil.